EX-10.1 2 mygn-ex101_186.htm EX-10.1

Exhibit 10.1

Attachment

Each of the following executive officers of Myriad Genetics, Inc. has entered into the Company’s standard form Executive Retention Agreement.

Executive Officer | Execution Date
Mark C. Capone, President and Chief Executive Officer | November 17, 2006, as amended October 12, 2007, and further amended September 29, 2015
Alexander Ford, President, Myriad Genetic Laboratories, Inc. | July 1, 2015, as amended September 29, 2015
Gary A. King, EVP International Operations | July 8, 2010, as amended September 29, 2015
Jerry S. Lanchbury, Ph.D., Chief Scientific Officer | February 17, 2005, as amended October 12, 2007, and further amended September 29, 2015
Richard M. Marsh, Esq., EVP, General Counsel and Secretary | February 17, 2005, as amended October 12, 2007, and further amended September 29, 2015
Ralph L. McDade, President, Myriad RBM, Inc. | September 29, 2015
R. Bryan Riggsbee, Chief Financial Officer and Treasurer | December 18, 2014, as amended September 29, 2015
Bernard F. Tobin, President, Crescendo Biosciences, Inc. | December 19, 2014, as amended September 29, 2015
Mark Verratti, President, Assurex Health, Inc. | September 19, 2017